Back to Search
Start Over
Treatment of Low-Risk Basal Cell Carcinoma.
- Source :
-
The Journal of investigative dermatology [J Invest Dermatol] 2017 Mar; Vol. 137 (3), pp. 539-540. - Publication Year :
- 2017
-
Abstract
- With the continuously rising incidence and changing populations of patients with basal cell carcinoma, evidence about the different treatment modalities is mandatory. Randomized clinical trials, such as the surgery versus imiquimod for nodular superficial basal cell carcinoma trial, can provide this evidence. Patients can then be informed about all aspects of alternative treatment options so that conscious, shared decisions can be made.<br /> (Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1523-1747
- Volume :
- 137
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- The Journal of investigative dermatology
- Publication Type :
- Academic Journal
- Accession number :
- 28235442
- Full Text :
- https://doi.org/10.1016/j.jid.2016.11.021